Amrize (NYSE:AMRZ) Rating Lowered to Hold at Berenberg Bank

Key Points

• Berenberg Bank downgraded Amrize from Buy to Hold and cut its price target from $48 to $46, implying about 9.8% upside from the current share price.
• Analyst sentiment is mixed but averages to Hold: eight analysts rate the stock Buy, seven Hold, and four Sell, with a consensus price target of $47.65.
• Amrize reported quarterly EPS of $1.05, matching estimates, and revenue of $3.77 billion, up 2.6% year over year.

Amrize (NYSE:AMRZ - Get Free Report) was downgraded by equities research analysts at Berenberg Bank from a "buy" rating to a "hold" rating in a research note issued to investors on Monday, FinViz reports. They presently have a $46.00 price target on the stock, down from their previous price target of $48.00. Berenberg Bank's target price indicates a potential upside of 9.79% from the stock's current price.

Several other analysts also recently issued reports on AMRZ. UBS Group dropped their price target on Amrize from $57.00 to $42.00 and set a "neutral" rating on the stock in a research note on Tuesday, September 22nd. Bank of America cut Amrize from a "neutral" rating to an "underperform" rating and reduced their price objective for the stock from $50.00 to $40.00 in a research report on Wednesday, September 2nd. Oppenheimer reduced their price objective on Amrize from $55.00 to $52.00 and set an "outperform" rating for the company in a research report on Monday, November 2nd. Longbow Research assumed coverage on Amrize in a report on Monday, October 12th. They set a "buy" rating for the company. Finally, Royal Bank Of Canada dropped their target price on Amrize from $48.00 to $32.00 and set an "underperform" rating on the stock in a research report on Friday, October 9th. Eight equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $47.65.

Amrize Stock Up 0.1%

Amrize stock opened at $41.90 on Monday. The company has a 50 day moving average of $39.53 and a 200-day moving average of $50.30. The company has a quick ratio of 0.67, a current ratio of 1.07 and a debt-to-equity ratio of 0.33. Amrize has a twelve month low of $35.78 and a twelve month high of $65.94. The stock has a market capitalization of $23.17 billion, a PE ratio of 18.96, a price-to-earnings-growth ratio of 1.64 and a beta of 0.03.

Amrize (NYSE:AMRZ - Get Free Report) last issued its quarterly earnings data on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, hitting analysts' consensus estimates of $1.05. The business had revenue of $3.77 billion for the quarter. Amrize had a net margin of 9.93% and a return on equity of 10.02%. The company's revenue was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.98 earnings per share. On average, equities research analysts anticipate that Amrize will post 2.30 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Jacques Sanche bought 4,150 shares of the company's stock in a transaction that occurred on Wednesday, August 26th. The shares were acquired at an average price of $45.02 per share, for a total transaction of $186,833.00. Following the completion of the acquisition, the director owned 9,766 shares of the company's stock, valued at approximately $439,665.32. The trade was a 73.90% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Jaime Hill purchased 1,500 shares of Amrize stock in a transaction that occurred on Tuesday, August 11th. The shares were bought at an average cost of $47.12 per share, with a total value of $70,680.00. Following the completion of the transaction, the insider directly owned 29,698 shares of the company's stock, valued at approximately $1,399,369.76. The trade was a 5.32% increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired 48,983 shares of company stock valued at $2,158,755 in the last quarter. 0.54% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Caldwell Sutter Capital Inc. lifted its holdings in Amrize by 11.5% during the 1st quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company's stock valued at $150,000 after purchasing an additional 275 shares during the last quarter. Grove Bank & Trust increased its holdings in shares of Amrize by 2.1% in the third quarter. Grove Bank & Trust now owns 17,477 shares of the company's stock valued at $653,000 after purchasing an additional 353 shares during the last quarter. Norman Fields Gottscho Capital Management LLC increased its holdings in shares of Amrize by 4.3% in the second quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company's stock valued at $614,000 after purchasing an additional 475 shares during the last quarter. Farther Finance Advisors LLC raised its position in shares of Amrize by 3.9% in the third quarter. Farther Finance Advisors LLC now owns 14,506 shares of the company's stock valued at $542,000 after purchasing an additional 543 shares during the period. Finally, Choreo LLC raised its position in shares of Amrize by 4.2% in the third quarter. Choreo LLC now owns 17,713 shares of the company's stock valued at $662,000 after purchasing an additional 706 shares during the period.

Amrize Company Profile

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets.

The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects.

Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim's North American business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.